Germany to allow some depressed patients to try psychedelics
It is the first time in the European Union that psilocybin – the hallucinogenic compound in magic mushrooms – will be made available through a compassionate use scheme, in which patients with serious or life-threatening illnesses can get access to drugs that have not yet been approved.
In Germany, psilocybin will only be prescribed in 'justified exceptional cases,' according to the Central Institute of Mental Health (CIMH), which asked regulators to greenlight the programme.
'This is an enormously important step that expands our scope for action,' Dr Gerhard Gründer, head of CIMH's molecular neuroimaging department, said in a statement.
In some cases, psilocybin therapy 'can be a medically and ethically justifiable option, provided it is carried out under strictly controlled conditions and with careful medical supervision,' Gründer added.
Depression is a common mental health problem, but approximately 20 per cent to 30 per cent of people with depression do not respond well to standard treatments, CIMH said.
Studies have shown that psilocybin could be a promising alternative for these patients. The drug is thought to foster connections between different regions of the brain, helping people let go of excessive self-focus and rumination, according to scientists from the United Kingdom and United States.
But sceptics have warned that studies on psychedelic drugs can be hard to replicate.
Growing interest in psychedelics
The decision from Germany's Federal Institute for Drugs and Medical Devices (BfArM) reflects growing interest in psychedelic therapies, including psilocybin and MDMA, as a treatment for mental health issues such as depression, anxiety, addiction, and post-traumatic stress disorder (PTSD).
Earlier this month, the Czech Republic legalised the medical use of psilocybin for conditions such as depression.
Meanwhile, the first EU-funded trial on psychedelic medicines launched last year to test whether psilocybin can alleviate anxiety and depression among patients with progressive diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).
Other clinical trials are also underway in Europe, including in Germany, though full approval for psilocybin is not expected in Germany for several years.
In the meantime, the Psychedelic Access And Research European Alliance (PAREA), a nonprofit advocacy group, said compassionate use programmes can complement clinical trials by offering real-world data on these treatments and ensuring they are available for 'patients who cannot wait' for full approval.
CIMH expects that many patients will be interested in Germany's limited access scheme.
'Experience from Switzerland shows that demand far exceeds the available supply,' Gründer said.
'We must therefore continue to work on bringing psychedelics such as psilocybin into standard care for the treatment of mental illness,' he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
France 24
2 hours ago
- France 24
Humanitarian situation in Gaza still very severe, EU official says
The humanitarian situation in Gaza continues to be very severe, an EU official told Reuters after the EU's foreign policy and humanitarian arms updated member countries late on Wednesday on the status of an agreement reached with Israel last month on boosting humanitarian access to Gaza. The official said on Thursday that there were some positive developments regarding fuel delivery, the reopening of some routes, and an upward trend in the number of daily trucks entering the enclave and the repair of some vital infrastructure. However, the official added that "significant obstructive factors continue to undermine humanitarian operations and aid delivery to Gaza, notably the lack of a safe operating environment to allow the distribution of aid at scale". 02:24 Israel enforced a complete blockade on food and other supplies for two-and-a-half months beginning in March. Though the flow of aid resumed in May under mounting international outrage, the amount that Israel is letting into the besieged territory is a fraction of what aid organisations say is needed. The UN has warned that a famine is unfolding in the besieged territory, which is home to more than two million Palestinians. At least 38 Palestinians were killed on Wednesday in the Gaza Strip while seeking aid from United Nations convoys and sites run by Israeli-backed American contractor Global Humanitarian Foundation, according to local health officials. Another 25 people, including several women and children, were killed in Israeli air strikes, according to local hospitals in Gaza. The military maintains that it only targets Hamas militants.
Euronews
17 hours ago
- Euronews
Who are the people driving up gambling statistics in Europe?
The number of customers in the European Union and the United Kingdom on online gambling platforms reached 38.6 million last year, representing a 19% increase from the 32.5 million recorded in 2023, according to the European Gaming and Betting Association (EGBA). While this is an upward trend over the past five years, the number of people looking for help to stop gambling addiction across Europe has also increased. Data from The Lancet from 2024 claims that 54.7 million men worldwide experienced gambling disorders or problematic gambling, compared to 25.3 million women. Gambling can lead to serious harms to health, including financial stress, relationship breakdown, family violence, mental illness and suicide, according to the World Health Organisation (WHO). EGBA's members represent approximately 30% of Europe's 2024 online gambling gross gaming revenue. Its members include Bet365 and Entain, which owns Ladbrokes and Paddy Power. In 2024, three-quarters of customers were male, marking an increase from 72% in 2023. Among women, this figure dropped from 28% in 2023 to 25% in 2024. People aged between 26 and 35 years and between 36 and 50 years make up the biggest share of gamblers, each representing 29% of customers. In Europe, online casinos currently remain the largest contributor at €21.5 billion, followed by sports and events betting at €13.7 billion. Both are projected to grow by around 7% annually until 2029. As a result, EU and national lawmakers are tightening rules and aim to combat the trivialisation of gambling. For instance, Germany prohibits online gambling altogether, while other member states allow it but only under restricted circumstances. Gambling among young students Although underage gambling is illegal in European countries, a 2024 study conducted by the European School Survey Project on Alcohol and Other Drugs (ESPAD) reveals that, on average, 23% of students aged 15 to 16 across 37 European countries reported having gambled for money in the past 12 months. This gambling occurred either in person or online and involved games of chance, such as slot machines, card games, dice games, lotteries, or betting on sports and animal races. Italy has the highest prevalence of gambling among students, at 45%, followed by Greece, at 36%. In contrast, the lowest rate is observed in Georgia, at 9.5%. A 2025 study conducted by Italian researchers using ESPAD data found that Southern European and Balkan countries are in the high-prevalence group, while Eastern European countries fall into the medium-prevalence group. Scandinavian and Central European countries predominantly belong to the low-prevalence group. Experts have also noted that while women are less likely to start gambling, they tend to progress to problem gambling more quickly. Online gambling has also seen a considerable growth, with participation rates growing by more than half among boys, from 13% in 2019 to 20% in 2024, and tripling among girls, from 2.7% in 2019 to 8.7% in 2024. The percentage of student gamblers exhibiting a potentially harmful gambling profile has increased notably, nearly doubling from 4.7% in 2019 to 8.5% in 2024. While this proportion remains much higher among boys, the increase is more pronounced among girls. "Environmental and contextual factors play a more significant role in initiating gambling behaviour, while individual characteristics have a greater impact on the likelihood of being at risk," researchers Elisa Benedetti, Gabriele Lombardi, Rodolfo Cotichini, Sonia Cerrai, Marco Scalese, and Sabrina Molinaro stated in the study.
Euronews
6 days ago
- Euronews
Trump officials weigh fate of European contraceptive stockpile
The Trump administration says it is weighing what to do with family planning supplies stockpiled in Europe that campaigners and two United States senators are fighting to save from destruction. Concerns that the Trump administration plans to incinerate the stockpile have angered family planning advocates on both sides of the Atlantic. Campaigners say the supplies stored in a US-funded warehouse in Geel, Belgium, include contraceptive pills, contraceptive implants, and IUDs that could spare women in war zones and elsewhere the hardship of unwanted pregnancies. US State Department deputy spokesman Tommy Pigott said Thursday in response to a question about the contraceptives that 'we're still in the process here in terms of determining the way forward'. "When we have an update, we'll provide it," he said. Belgium says it has been talking with US diplomats about trying to spare the supplies from destruction, including possibly moving them out of the warehouse. Foreign Ministry spokesperson Florinda Baleci told The Associated Press that she couldn't comment further 'to avoid influencing the outcome of the discussions'. The Trump administration's dismantling of the US Agency for International Development (USAID), which managed foreign aid programmes, left the supplies' fate uncertain. Pigott didn't detail the types of contraceptives that make up the stockpile. He said some of the supplies, bought by the previous administration, could 'potentially be' drugs designed to induce abortions. Pigott didn't detail how that might impact the Trump administration thinking about how to deal with the drugs or the entire stockpile. Costing more than $9 million (€7.9 million) and funded by US taxpayers, the family planning supplies were intended for women in war zones, refugee camps, and elsewhere, according to a bipartisan letter of protest to US Secretary of State Marco Rubio from US senators Jeanne Shaheen, a New Hampshire Democrat, and Alaska Republican Lisa Murkowski. They said destroying the stockpile 'would be a waste of US taxpayer dollars as well as an abdication of US global leadership in preventing unintended pregnancies, unsafe abortions and maternal deaths – key goals of US foreign assistance'. They urged Rubio to allow another country or partner to distribute the contraceptives. European lawmakers, aid groups voice concerns Concerns voiced by European campaigners and lawmakers that the supplies could be transported to France for incineration have led to mounting pressure on government officials to intervene and save them. The European Commission, through spokesman Guillaume Mercier, said Friday that 'we continue to monitor the situation closely to explore the most effective solutions'. The US branch of family planning aid group MSI Reproductive Choices said it offered to purchase, repackage, and distribute the stock at its own expense but 'these efforts were repeatedly rejected'. The group said the supplies included long-acting IUDs, contraceptive implants, and pills, and that they have long shelf-lives, extending as far as 2031. Aid group Doctors Without Borders said incineration would be 'an intentionally reckless and harmful act against women and girls everywhere'. Charles Dallara, the grandson of a French former lawmaker who was a contraception pioneer in France, urged President Emmanuel Macron to not let France 'become an accomplice to this scandal'. 'Do not allow France to take part in the destruction of essential health tools for millions of women,' Dallara wrote in an appeal to the French leader. 'We have a moral and historical responsibility'.
